STRATAFIX Spiral PRONOVA Unidirectional Knotless Tissue Control Device STRATAFIX Spiral PRONOVA Bidirectional Knotless Tissue Control Device
ETHICON, Inc. · Decision date Mar 27, 2026
What did the FDA decide?
FDA records K253572 as a 510(k) premarket notification, with a decision dated Mar 27, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Mar 27, 2026
Regulatory record facts
- Identifier
- K253572
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ETHICON, Inc.
- Product code
- GAW
- Decision code
- SESE
- Decision date
- Mar 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Suture, Nonabsorbable, Synthetic, Polypropylene.
- Applicant
- ETHICON, Inc.
- Product code
- GAW
- FDA device class
- 2
FDA decision timeline
K253572 received
Application receipt date recorded by FDA.
K253572 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ETHICON, Inc.
- Headquarters
- Not reported
- Brand website
- ethicon.com
- FDA applicant address
- Raritan, NJ
Sources and methodology
- Original FDA record: K253572
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records